{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:07:53Z","timestamp":1791259673406,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.disamonth.2012.01.011","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T19:15:19Z","timestamp":1332530119000},"page":"219-238","source":"Crossref","is-referenced-by-count":36,"title":["Adult Acute Leukemia"],"prefix":"10.1016","volume":"58","author":[{"given":"Robert Frank","family":"Cornell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"60","key":"10.1016\/j.disamonth.2012.01.011_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics","volume":"2010","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.disamonth.2012.01.011_bib2","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish acute leukemia registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib5","first-page":"47","article-title":"Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure","volume":"19","author":"Levine","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/oxfordjournals.aje.a114820","article-title":"Benzene and leukemia","volume":"127","author":"Austin","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.disamonth.2012.01.011_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423","article-title":"Leukemia and lymphoma in ataxia telangiectasia","volume":"87","author":"Taylor","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib9","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJM197612022952315","article-title":"Acute leukemia in Down's syndrome","volume":"295","author":"Rosner","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2012.01.011_bib10","first-page":"937","article-title":"The incidence of secondary leukemias","volume":"84","author":"Leone","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.disamonth.2012.01.011_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JCO.1986.4.3.325","article-title":"Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7","volume":"4","author":"Le Beau","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199309233291302","article-title":"Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations","volume":"329","author":"Thirman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2012.01.011_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0733-8635(18)30190-6","article-title":"Leukemia cutis","volume":"12","author":"Ratnam","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.disamonth.2012.01.011_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1988.6.3.495","article-title":"High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia","volume":"6","author":"Cassileth","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib15","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1989.tb07677.x","article-title":"Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy","volume":"72","author":"Campos","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib17","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.disamonth.2012.01.011_bib18","first-page":"S45","article-title":"Impact of karyotype on treatment outcome in acute myeloid leukemia","volume":"83","author":"Grimwade","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.2006.06276.x","article-title":"The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations","volume":"135","author":"Appelbaum","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib21","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/cncr.25598","article-title":"Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome","volume":"117","author":"Bello","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib24","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1182\/blood-2005-05-2168","article-title":"Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance","volume":"106","author":"Verhaak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib25","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2006-07-012252","article-title":"Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc+ AML): biologic and clinical features","volume":"109","author":"Falini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib26","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa074306","article-title":"Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia","volume":"358","author":"Schlenk","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2012.01.011_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrc1363","article-title":"C\/EBPalpha mutations in acute myeloid leukaemias","volume":"4","author":"Nerlov","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/1097-0142(20010901)92:5<1059::AID-CNCR1421>3.0.CO;2-K","article-title":"Therapeutic options for acute myelogenous leukemia","volume":"92","author":"Estey","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib29","first-page":"57","article-title":"The treatment of adult acute myeloid leukemia","volume":"24","author":"Bishop","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib30","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2010-03-273243","article-title":"Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 study","volume":"117","author":"Ohtake","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib31","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1182\/blood.V88.8.2841.bloodjournal8882841","article-title":"A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study","volume":"88","author":"Weick","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1182\/blood.V87.5.1710.1710","article-title":"A randomized study of high-dose cytarabine in induction in acute myeloid leukemia","volume":"87","author":"Bishop","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood-2002-02-0532","article-title":"Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 trial","volume":"101","author":"Kern","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1200\/JCO.1988.6.4.583","article-title":"Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia","volume":"6","author":"Cassileth","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib35","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/cncr.20945","article-title":"Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis","volume":"103","author":"Yanada","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib36","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2009.813","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials","volume":"301","author":"Koreth","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2012.01.011_bib37","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199812033392301","article-title":"Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission","volume":"339","author":"Cassileth","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2012.01.011_bib38","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.11240","article-title":"Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia","volume":"97","author":"Tsimberidou","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib39","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1200\/JCO.2005.06.027","article-title":"Prognostic index for adult patients with acute myeloid leukemia in first relapse","volume":"23","author":"Breems","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2141.2004.05318.x","article-title":"Biology and management of relapsed acute myeloid leukaemia","volume":"129","author":"Craddock","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib41","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/cncr.21723","article-title":"Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib42","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/blood.V98.5.1312","article-title":"The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial","volume":"98","author":"Grimwade","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib43","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1200\/JCO.2008.21.0674","article-title":"Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup","volume":"27","author":"Pr\u00e9bet","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00000421-199804000-00009","article-title":"Treatment of acute myelogenous leukemia in the older patient with attenuated high-dose ara-C","volume":"21","author":"Letendre","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib45","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/cncr.22204","article-title":"Treatment of acute myelogenous leukemia with outpatient azacitidine","volume":"107","author":"Sudan","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM199410063311402","article-title":"Intensive postremission chemotherapy in adults with acute myeloid leukemia","volume":"331","author":"Mayer","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2012.01.011_bib47","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/blood.V98.3.548","article-title":"Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine","volume":"98","author":"Stone","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib48","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2003.09.110","article-title":"Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia","volume":"21","author":"Bertz","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1200\/JCO.2005.03.1765","article-title":"Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors","volume":"24","author":"Hegenbart","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-3476(98)70100-3","article-title":"Congenital abnormalities in children with acute leukemia: a report from the children's Cancer Group","volume":"133","author":"Mertens","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.disamonth.2012.01.011_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/adc.85.4.321","article-title":"Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment","volume":"85","author":"Chessells","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.disamonth.2012.01.011_bib52","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/1097-0142(19800401)45:7<1675::AID-CNCR2820450725>3.0.CO;2-D","article-title":"Ataxia-telangiectasia and acute lymphoblastic leukemia","volume":"45","author":"Toledano","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08880019209006400","article-title":"Acute lymphoblastic leukemia and Klinefelter's syndrome","volume":"9","author":"Shaw","year":"1992","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib54","first-page":"349","article-title":"An infectious etiology for common acute lymphoblastic leukemia in childhood?","volume":"7","author":"Greaves","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.disamonth.2012.01.011_bib55","first-page":"336","article-title":"HTLV-1 and associated adult T-cell leukemia\/lymphoma","volume":"7","author":"Mahieux","year":"2003","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib56","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V84.5.1603.bloodjournal8451603","article-title":"Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87)","volume":"84","author":"Boucheix","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib57","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood.V79.3.666.666","article-title":"Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow","volume":"79","author":"Terstappen","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib58","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-10-116186","article-title":"Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study","volume":"111","author":"Pullarkat","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib59","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib60","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.04948.x","article-title":"Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia","volume":"125","author":"Harrison","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib61","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","article-title":"NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study","volume":"113","author":"Asnafi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib62","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2141.2005.05497.x","article-title":"Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group study","volume":"129","author":"Harrison","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib63","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1182\/blood.V86.10.3876.bloodjournal86103876","article-title":"Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23)","volume":"86","author":"Hilden","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib64","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1182\/blood-2009-09-241943","article-title":"High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia","volume":"115","author":"K\u00fchnl","year":"2010","journal-title":"Blood"},{"issue":"106","key":"10.1016\/j.disamonth.2012.01.011_bib65","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","article-title":"Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG","volume":"E2993","author":"Rowe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib66","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1182\/blood-2006-07-037093","article-title":"Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06\/99 and 07\/03 trials","volume":"109","author":"Raff","year":"2007","journal-title":"Blood"},{"issue":"80","key":"10.1016\/j.disamonth.2012.01.011_bib67","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V80.12.2983.2983","article-title":"Clinical significance of the bcr-abl fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study","volume":"8762","author":"Westbrook","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib68","first-page":"3983","article-title":"Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia group B experience","volume":"93","author":"Wetzler","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3324\/haematol.2009.015974","article-title":"Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"95","author":"Fielding","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.disamonth.2012.01.011_bib70","first-page":"821","article-title":"Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes","volume":"9","author":"Devaraj","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.disamonth.2012.01.011_bib71","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL recombinome of acute leukemias","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.disamonth.2012.01.011_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V71.1.123.123","article-title":"Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults","volume":"71","author":"Hoelzer","year":"1988","journal-title":"Blood"},{"issue":"108","key":"10.1016\/j.disamonth.2012.01.011_bib73","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood-2005-11-4666","article-title":"Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII\/ECOG","volume":"E2993","author":"Lazarus","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib74","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","article-title":"Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia","volume":"107","author":"Br\u00fcggemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib75","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811","volume":"85","author":"Larson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib76","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib77","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1200\/JCO.2009.26.9456","article-title":"Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia","volume":"28","author":"Thomas","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib78","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2010.28.1287","article-title":"Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09\/00","volume":"28","author":"Bassan","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib79","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2005.03.2177","article-title":"High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed bcr-abl-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group","volume":"24","author":"Yanada","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib80","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cncr.10265","article-title":"Central nervous system relapse in adults with acute lymphoblastic leukemia","volume":"94","author":"Surapaneni","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.011_bib81","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1200\/JCO.1993.11.5.839","article-title":"Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"11","author":"Pullen","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib82","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0889-8588(05)70190-8","article-title":"Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation","volume":"14","author":"Thiebaut","year":"2000","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"10.1016\/j.disamonth.2012.01.011_bib83","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"Goldstone","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib84","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10552-007-9097-2","article-title":"Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002","volume":"19","author":"Yamamoto","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.disamonth.2012.01.011_bib85","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood.V75.11.2112.2112","article-title":"Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia","volume":"75","author":"Rodeghiero","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib86","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM199105163242002","article-title":"Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)","volume":"324","author":"Warrell","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2012.01.011_bib87","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1998.16.1.78","article-title":"Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy","volume":"16","author":"Asou","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.011_bib88","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V82.11.3241.3241","article-title":"Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia","volume":"82","author":"Fenaux","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib89","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","article-title":"Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin","volume":"111","author":"de la Serna","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.011_bib90","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1182\/blood-2010-02-269621","article-title":"Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American leukemia intergroup study","volume":"116","author":"Powell","year":"2010","journal-title":"Blood"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502912000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502912000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T18:26:38Z","timestamp":1593887198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502912000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0011502912000120"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2012.01.011","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}